article thumbnail

The Mylan EpiPen Debacle: How Tremendous Greed Can Lead to the Demise of a Leader

N2Growth Blog

As you have likely heard, the pharmaceutical company Mylan and its CEO, Heather Bresch, have come under immense scrutiny for the firm’s EpiPen pricing policy. ” “The reality is and the brand pharmaceutical market, this isn’t an EpiPen issue. peanuts, shellfish, insect bites etc.). This isn’t a Mylan issue.

article thumbnail

How to Advance Your Career in HR

HR Digest

They manage employee relations, recruit new employees, train them, and provide benefits. Other common employers include healthcare facilities, insurance providers, financial institutions, and pharmaceutical companies. As of 2015, Fortune 500 companies are hiring more HR professionals than ever before. Top Companies .

Career 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Adding Too Much Value

Marshall Goldsmith

Garnier, former CEO of the large pharmaceutical company GlaxoSmith Kline, “What did you learn from me when I was your executive coach that helped you the most as a leader?” Dr. Marshall Goldsmith was selected as one of the 10 Most Influential Management Thinkers in the World by Thinkers50 in both 2011 and 2013. 1-858-759-0950.

article thumbnail

Health Systems Need to Completely Reassess How They Manage Costs

Harvard Business Review

hospitals and health systems experienced an average 39% reduction in their operating margins from 2015 to 2017. Eliminating layers of management. One thing that distinguishes the typical nonprofit from a comparably-sized investor-owned hospital is the number of layers of management. PM Images/Getty Images. As the U.S.

Cost 10
article thumbnail

Research: Business School Really Does Influence How Students Make Decisions Later On

Harvard Business Review

Through his academic research and teaching at HBS, Jensen promulgated a new financial orthodoxy that corporate managers should avoid diversification and instead focus on the firm’s core competencies. corporations from 1985 to 2015. firms, and put the brakes on diversification.

article thumbnail

The Right Way to Use Analytics Isn’t for Planning

Harvard Business Review

In July 2015, Novartis launched its new heart failure drug, Entresto, which Forbes in 2014 predicted would be a blockbuster — with expected sales of $10 billion annually — as the potential market in the US exceeds 5 million people with a heart failure condition. What builds management perspectives? Laura Schneider for HBR.

article thumbnail

Innovation Should Be a Top Priority for Boards. So Why Isn’t It?

Harvard Business Review

In contrast, 70% of respondents think their boards have effective processes for staying current on the company; 69% for compliance; 66% for financial planning; and 55% for risk management — although we should note that managing risks is a crucial consideration when pursuing innovation.